Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis
Author:
Affiliation:
1. Department of Pharmacy, University of Louisville Hospital; Louisville Kentucky
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dth.12758/fullpdf
Reference18 articles.
1. Severe cutaneous adverse drug reactions;Chung;Journal of Dermatology,2016
2. An overview of immunosuppression in solid organ transplantation;Enderby;American Journal of Managed Care,2015
3. Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: Evidence from three different approaches;González-Herrada;Journal of Investigative Dermatology,2017
4. Immunosuppressive effects of cyclosporin A on cloned T cells;Herold;The Journal of Immunology,1986
5. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: Results from a prospective 12-month nonrandomized unblinded clinical trial;Karanikolas;The Journal of Rheumatology,2011
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stevens–Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and management;Chinese Medical Journal;2024-09-05
2. Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review;British Journal of Clinical Pharmacology;2024-05-27
3. Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients;Dermatology and Therapy;2024-05-17
4. Antiepileptic Medication-induced Severe Cutaneous Adverse Reactions in Hospitalized Children: A Retrospective Study;Iranian Journal of Allergy, Asthma and Immunology;2024-04-14
5. A retrospective analysis of mortality risk and immunosuppressive therapy for Stevens-Johnson Syndrome and toxic epidermal necrolysis syndrome using the TriNetX research network;Burns;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3